Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay
- PMID: 3245859
Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay
Abstract
The human blanching assay was used to assess the potency of two new proprietary corticosteroid creams. The blanching abilities of 0.1% desonide cream and 0.05% halometasone cream were evaluated relative to the blanching elicited by 0.05% clobetasol 17-propionate cream, 0.1% betamethasone 17-valerate cream and 0.05% clobetasone 17-butyrate cream. The results of the trial indicated that the 0.1% desonide cream falls into the potent group of topical corticosteroid preparations and the 0.05% halometasone cream falls into the moderately potent group.
Similar articles
-
[Comparative study of efficacy and effect on plasma cortisol levels of micronised desonide cream 0.1 p. 100 versus betamethasone dipropionate cream 0.05 p. 100 In the treatment of childhood atopic dermatitis].Ann Dermatol Venereol. 2000 Jun-Jul;127(6-7):590-5. Ann Dermatol Venereol. 2000. PMID: 10930856 Clinical Trial. French.
-
[Testing the loss of efficacy (tachyphylaxis) during external steroid application].Hautarzt. 1985 Mar;36(3):146-9. Hautarzt. 1985. PMID: 3997512 German.
-
An overview of international clinical trials with halometasone cream.J Int Med Res. 1983;11 Suppl 1:1-7. J Int Med Res. 1983. PMID: 6339286 Clinical Trial.
-
Overview on desonide 0.05%: a clinical safety profile.J Drugs Dermatol. 2004 Jul-Aug;3(4):393-7. J Drugs Dermatol. 2004. PMID: 15303783 Review.
-
Desonide foam: a review.Drugs Today (Barc). 2008 Jan;44(1):55-62. doi: 10.1358/dot.2008.44.1.1143847. Drugs Today (Barc). 2008. PMID: 18301804 Review.
Cited by
-
Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio.Drug Saf. 1994 May;10(5):406-12. doi: 10.2165/00002018-199410050-00005. Drug Saf. 1994. PMID: 8037890 Review.